Abstract:Eight previously undescribed lanostane triterpenoids, ganodeweberiols A ∼ H (1–8), together with eighteen known compounds (9–26), were isolated from the fruiting bodies of Ganoderma weberianum. The structures and absolute configurations of the new compounds were determined by extensive spectroscopic analysis, as well as NMR chemical shifts and electronic circular dichroism (ECD) calculations. Compounds 2, 7, 12, and 14 showed significant α-glucosidase inhibitory activity with IC50 values ranging from 35.3 μM ∼ 223.4 μM compared to the positive control acarbose (IC50, 304.6 μM). Kinetic study indicated that the most potent compound 12 was a mixed type inhibitor for α-glucosidase. Molecular docking simulation revealed the interactions of 12 with α-glucosidase. Additionally, Compounds 3 and 6 inhibited glucagon-induced hepatic glucose production in HepG2 cells with EC50 values of 42.0 and 85.9 μM, respectively. Further study revealed that compounds 3 and 6 inhibited hepatic glucose production by suppression glucagon-induced cAMP accumulation. Moreover, compounds 3 and 26 were active against HeLa cell line with IC50 values of 17.0 and 6.8 μM, respectively.

Lanostanoids isolated from Ganoderma lucidum mycelium cultured by submerged fermentation

New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

Structure Elucidation and Complete NMR Spectral Assignments of Three New Lanostanoid Triterpenes with Unprecedented Δ16, 17 Double Bond from Ganoderma Lucidum

[Triterpenoids from Ganoderma theaecolum]

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Isolation of 3,4-Seco-27-norlanostane Triterpenoids from Cultivated Fruiting Bodies of Ganoderma Orbiforme

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

A New Ganoderic Acid from Ganoderma Lucidum Mycelia

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

A new ganoderic acid from Ganoderma lucidum mycelia and its stability.

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Applanaic acids A–C, three new highly oxygenated lanostane triterpenoids from the fruiting bodies of Ganoderma applanatum

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Two new lanostane triterpenoids from Poria cocos

Lanostane triterpenoids from cultivated fruiting bodies of Ganoderma sichuanense: Determination of the C-25 absolute configuration of ganoderic acid A and its derivatives using the phenylglycine methyl ester (PGME) method

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Minor ergosteroids and a 19- nor labdane-type diterpenoid with anti-inflammatory effects from Ganoderma lucidum

Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH